Sysmex releases transcript of Q1 FY2027 financial results presentation

• Sysmex released a Q&A transcript from its financial results presentation for the first three months of fiscal 2027, attended by executives.
• China performance tracked expectations; distributor inventory adjustments stayed within assumptions, with pricing-standardization policy impact still uncertain.
• Pilot price standardization ran in six provinces in early August; formal details expected late August, with nationwide rollout planned from September to December.
• First-half and full-year forecasts were raised on stronger Americas momentum, led by smoother North America hematology installations for previously received orders.
• Full-year outlook includes JPY 4.5 billion one-time expenses in Q2; second-half assumptions held pending China pricing policy clarity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sysmex Corporation published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.